Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation

2013 ◽  
pp. 597-634 ◽  
Author(s):  
Mariacristina Chioda ◽  
Ilaria Marigo ◽  
Susanna Mandruzzato ◽  
Simone Mocellin ◽  
Vincenzo Bronte
2020 ◽  
Vol 176 ◽  
pp. 113887 ◽  
Author(s):  
Xunzhen Zheng ◽  
Veani Fernando ◽  
Vandana Sharma ◽  
Yashna Walia ◽  
Joshua Letson ◽  
...  

Nitric Oxide ◽  
1999 ◽  
Vol 3 (4) ◽  
pp. 302-311 ◽  
Author(s):  
Yehia A.-G. Mahmoud ◽  
Koichi Harada ◽  
Akitoshi Nagasaki ◽  
Tomomi Gotoh ◽  
Motohiro Takeya ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e96508 ◽  
Author(s):  
Yunwei Lou ◽  
Guizhong Zhang ◽  
Minghong Geng ◽  
Wenqian Zhang ◽  
Jian Cui ◽  
...  

1998 ◽  
Vol 30 (3) ◽  
pp. 319-324 ◽  
Author(s):  
Anália do Carmo ◽  
Celeste Lopes ◽  
Maria Santos ◽  
Rui Proença ◽  
José Cunha-Vaz ◽  
...  

1994 ◽  
Vol 267 (4) ◽  
pp. F646-F653 ◽  
Author(s):  
H. T. Cook ◽  
A. Jansen ◽  
S. Lewis ◽  
P. Largen ◽  
M. O'Donnell ◽  
...  

L-Arginine is metabolized by two pathways: 1) by nitric oxide synthase (NOS) to nitric oxide (NO) and 2) by arginase forming urea and L-ornithine. Inflammatory responses may involve a balance between the pathways, as NO is cytotoxic and vasodilatory and L-ornithine is a promoter of cell proliferation and matrix synthesis. In experimental glomerulonephritis we have previously shown that NOS is activated in nephritic glomeruli. We have now examined both pathways of L-arginine metabolism to study competition for L-arginine, temporal variation, and the sources of NOS and arginase. Acute in situ glomerulonephritis was induced in rats, and glomeruli were studied at 1, 4, and 7 days. Both NOS and arginase activities were present. There was temporal variation: NOS activity was highest on day 1 and arginase activity on day 4; both declined by day 7. Competition between the pathways was demonstrated by increased urea synthesis in the presence of NG-monomethyl-L-arginine, an inhibitor of NOS. Measurement of NOS and arginase activities in macrophages isolated from nephritic glomeruli showed that these cells were a major source of glomerular NOS but not arginase activity. In contrast, high arginase activity but low NO production was identified in cultured rat glomerular mesangial cells. These studies show differential temporal variation in expression of NOS and arginase pathways of arginine metabolism in experimental glomerulonephritis. We have found two factors that may contribute to this: 1) competition for substrate L-arginine between the two pathways and 2) different cellular sources. We hypothesize that the balance between these pathways is a mechanism regulating injury, hemodynamics, and mesangial cell proliferation.


1998 ◽  
Vol 336 (1) ◽  
pp. 1-17 ◽  
Author(s):  
Guoyao WU ◽  
Sidney M. MORRIS

Arginine is one of the most versatile amino acids in animal cells, serving as a precursor for the synthesis not only of proteins but also of nitric oxide, urea, polyamines, proline, glutamate, creatine and agmatine. Of the enzymes that catalyse rate-controlling steps in arginine synthesis and catabolism, argininosuccinate synthase, the two arginase isoenzymes, the three nitric oxide synthase isoenzymes and arginine decarboxylase have been recognized in recent years as key factors in regulating newly identified aspects of arginine metabolism. In particular, changes in the activities of argininosuccinate synthase, the arginases, the inducible isoenzyme of nitric oxide synthase and also cationic amino acid transporters play major roles in determining the metabolic fates of arginine in health and disease, and recent studies have identified complex patterns of interaction among these enzymes. There is growing interest in the potential roles of the arginase isoenzymes as regulators of the synthesis of nitric oxide, polyamines, proline and glutamate. Physiological roles and relationships between the pathways of arginine synthesis and catabolism in vivo are complex and difficult to analyse, owing to compartmentalized expression of various enzymes at both organ (e.g. liver, small intestine and kidney) and subcellular (cytosol and mitochondria) levels, as well as to changes in expression during development and in response to diet, hormones and cytokines. The ongoing development of new cell lines and animal models using cDNA clones and genes for key arginine metabolic enzymes will provide new approaches more clearly elucidating the physiological roles of these enzymes. Correspondence may be addressed to either Dr. G. Wu (e-mail [email protected]) or Dr. S. M. Morris, Jr. (e-mail [email protected]) at the addresses given.


Sign in / Sign up

Export Citation Format

Share Document